MRI artificial intelligence (AI) image analysis software developer Perspectum recently closed on its first round of Series C funding valued at $36 million, led by Oppenheimer Holdings.
Perspectum said that it will use the funding to scale its U.S. operations, as well as further develop its future software for multiorgan inflammatory conditions and oncology. HealthQuest Capital, the Blue Venture Fund, and British Patient Capital also participated in the funding round.
